Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IceCure Medical (ICCM) Shares Outstanding (2020 - 2025)

IceCure Medical (ICCM) has disclosed Shares Outstanding for 5 consecutive years, with $56.6 million as the latest value for Q4 2024.

  • On a quarterly basis, Shares Outstanding rose 23.7% to $56.6 million in Q4 2024 year-over-year; TTM through Dec 2024 was $56.6 million, a 23.7% increase, with the full-year FY2024 number at $56.6 million, up 23.7% from a year prior.
  • Shares Outstanding was $56.6 million for Q4 2024 at IceCure Medical, up from $45.7 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $56.6 million in Q4 2024 to a low of -$5434.0 in Q4 2020.
  • A 5-year average of $36.7 million and a median of $45.6 million in 2022 define the central range for Shares Outstanding.
  • Peak YoY movement for Shares Outstanding: skyrocketed 76.97% in 2021, then increased 0.23% in 2023.
  • IceCure Medical's Shares Outstanding stood at $20.2 million in 2020, then surged by 76.97% to $35.8 million in 2021, then increased by 27.51% to $45.6 million in 2022, then rose by 0.23% to $45.7 million in 2023, then grew by 23.7% to $56.6 million in 2024.
  • Per Business Quant, the three most recent readings for ICCM's Shares Outstanding are $56.6 million (Q4 2024), $45.7 million (Q4 2023), and $45.6 million (Q4 2022).